nach oben

Diabetology International

Erschienen in:

01.11.2010 | Review article

Insulin autoimmune syndrome (Hirata disease): epidemiology in Asia, including Japan

verfasst von: Yasuko Uchigata, Yukimasa Hirata, Yasuhiko Iwamoto

Erschienen in: Diabetology International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

As populations with a higher prevalence of HLADRB1*0406 have been found to have a higher risk of developing insulin autoimmune syndrome (IAS), we report here the clinical features of Asian and Japanese IAS. There was female dominance in the 20- to 49-year-old age group at the onset of IAS development. Forty-two percent of Japanese IAS patients had received drugs or α-lipoic acid containing the sulfhydryl group, while 81% of Asian IAS patients outside Japan had received methimazole or carbimazole before the development of IAS.

Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypoglycemia. J Jpn Diabetes Soc. 1970;13:312–20.

Uchigata Y, Eguchi Y, Takayama-Hasumi S, et al. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract. 1994;22:89–94.CrossRefPubMed

Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in incidence of insulin autoimmune syndrome (IAS, Hirata’s Disease) with respect to the evolution of HLA-DR4. Hum Genet. 2000;61:154–7.

Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine. 2009;88:141–53.CrossRefPubMed

Uchigata Y, Omori Y. Clinical characteristics of 212 patients with insulin autoimmune syndrome (Hirata Disease) (in Japanese). Hormone Pract. 1994;42(Suppl):229–32.

Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet. 1983; ii:1037–1038.

Uchigata Y, Kuwata S, Tsushima T, et al. Patients with Graves’ disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab. 1993;77:249–54.CrossRefPubMed

Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83:e19–20.CrossRefPubMed

Wasada T, Eguchi Y, Takayama S, Hirata Y, Ishii S. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Diabetes Care. 1989;12:147–50.CrossRefPubMed

10.

Murakami M, Mizuida M, Kashima K, Kojima A, Tomioka SI, Kohama T, Araki O, Ogiwara T, Mizuma H, Mori M. Identification of monoclonal insulin autoantibodies in insulin autoimmune syndrome associated with HLA-DRB1*0404. Hormone Res. 2000;54:49–52.PubMed

11.

Miyake T, Tsujimura F, Ito Y. A case of monoclonal insulin autoimmune syndrome with a suspected 20-year history: effect of one-year administration of prednisolone on insulin autoantibodies. J Jpn Diab Soc. 2009;52:45–9.

12.

Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes. 1995;44:1227–32.CrossRefPubMed

13.

Masjhur JS. Insulin autoimmune syndrome (Hirata’s Disease): severe hypoglycemic episodes in Graves’s hyperthyroidism patient treated with methimazole. Acta Media Indonesiana. 2005;37:214–6.

14.

Uchigata Y, Omori Y, Nieda M, et al. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet. 1992;340:1467.CrossRefPubMed

15.

Ito Y, Nieda M, Uchigata Y, et al. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol. 1993;15:5770–6.

16.

Miyamura N, Murata Y, Takeda K, Ichihara T, Matsumura H, Tokunaga K, Matsumoto M, Sakakida M, Araki E. A case of insulin autoimmune syndrome with HLADRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules. Diabet Med. 2006;23:103–6.CrossRef

17.

Kishikawa H, Okada Y, Hirose A, Kawahara T, Misawa H, Tanikawa T, Kanda K, Morita E, Tanaka Y. A case of insulin autoimmune syndrome whom the development of IAS was probably induced by Loxoprofen sodium. J Jpn Diab Soc. 2004;47:851–4.

18.

Benson EB, Ho P, Wang C, et al. Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med. 1984;144:2351–4.CrossRefPubMed

19.

Cho BY, Lee HK, Koh CS, et al. Spontaneous hypoglycemia and insulin autoantibodies in patients with Graves’ disease. Diabetes Res Clin Pract. 1987;3:119–24.CrossRefPubMed

20.

Lee Y-J, Shin S-J, Torng J-K, et al. Insulin autoimmune syndrome in a methimazole-treated Graves’ disease with polyclonal anti-insulin autoantibodies. J Formosa Med Assoc. 1987;867:164–70.

21.

Lin H-D, Chen H-D, Chang R-Y, Lin C-Y, Ching K-N. Insulin autoimmune syndrome in methimazole or carbimazole treated Chinese patients of Graves’ disease. Chin Med J. 1988;42:163–8.

22.

Wong ST, Ng WY, Thai AC. Case report: autoimmune insulin syndrome in a Chinese female with Graves’ disease. Ann Acad Med Singap. 1996;25:882–5.PubMed

23.

Chen C-H, Huang M-J, Huang B-Y, et al. Insulin autoimmune syndrome as a cause of hypoglycemia––report of four cases. Changgeng Yi Xue Za Zhi. 1990;13:134–42.PubMed

24.

Lu CC, Lee JK, Yang CY, Han TM. Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves’ disease: a case report. Chin Med J. 1994;54(5):353–8.

25.

Ma WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc. 2005;68:82–6.CrossRefPubMed

Titel: Insulin autoimmune syndrome (Hirata disease): epidemiology in Asia, including Japan
verfasst von: Yasuko Uchigata
Yukimasa Hirata
Yasuhiko Iwamoto
Publikationsdatum: 01.11.2010
Verlag: Springer Japan
Erschienen in: Diabetology International / Ausgabe 1/2010
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-010-0001-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Insulin autoimmune syndrome (Hirata disease): epidemiology in Asia, including Japan

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?

Diabetology International: our new official journal in English

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus

Leptin mediates the relationship between abdominal obesity and microalbuminuria in type 2 diabetic patients

Efficacy and adverse effects of low-dose nateglinide in early type 2 diabetes: comparison with acarbose in a crossover study

Different effects of islet transplantation and Detemir treatment on the reversal of streptozotocin-induced diabetes associated with β-cell regeneration

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin